X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

International Journal of Rheumatic Diseases

期刊標題檢索 INT J RHEUM DIS 最新評論: What is your current status? (2024-04-17)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[International Journal of Rheumatic Diseases]您好,您是該頁面的第 25428 位訪客。

期刊簡介
期刊名稱International Journal of Rheumatic Diseases International Journal of Rheumatic Diseases
LetPub Score
5.5
50 ratings
Rate

Reputation
6.4

Influence
4.0

Speed
9.7

期刊簡稱INT J RHEUM DIS
ISSN1756-1841
E-ISSN1756-185X
h-index33
CiteScore
CiteScoreSJRSNIPCiteScore Rank
3.700.6530.764
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Rheumatology
Q338 / 73

自引率 (2023-2024)20.80%自引率趨勢
掲載範囲
The International Journal of Rheumatic Diseases (formerly APLAR Journal of Rheumatology) is the official journal of the Asia Pacific League of Associations for Rheumatology. The Journal accepts original articles on clinical or experimental research pertinent to the rheumatic diseases, work on connective tissue diseases and other immune and allergic disorders. The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are peer reviewed by two anonymous reviewers and the Editor.
官方網站http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1756-185X
在線稿件提交https://mc.manuscriptcentral.com/aplar
開放訪問No
出版商Wiley-Blackwell Publishing Ltd
主題領域RHEUMATOLOGY
出版國/地區AUSTRALIA
發行頻率四半期刊行
創刊年2008
每年文章數274每年文章數趨勢
黃金OA百分比9.08%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
RHEUMATOLOGYSCIEQ226/57
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1756-1841%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 3 Month(s)
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【International Journal of Rheumatic Diseases】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    World PsychiatryH-index: 70

    CiteScore: 64.10
    學科內最受檢索的期刊 頁面查看次數
    MEDICINE640863
    BIOMATERIALS571718
    BIOMEDICINE & PHARMACOTHERAPY498358
    Frontiers in Pharmacology486985
    JOURNAL OF ETHNOPHARMACOLOGY478754
    Journal of Materials Chemistry B476062
    Frontiers in Immunology457945
    COLLOIDS AND SURFACES B-BIOINTERFACES419241
    COMPUTERS IN BIOLOGY AND MEDICINE416463
    Frontiers in Oncology413460
  •  

    International Journal of Rheumatic Diseases International Journal of Rheumatic Diseases
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [International Journal of Rheumatic Diseases] 的評論撰寫評論
作者: 龙爪乙丑


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-17 10:26:01 評論於
What is your current status?
(0) 讚! | 龙爪乙丑

作者: Georgia Needham


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-26 10:40:01 評論於
I feel the same way. It's been over a month under review and still awaiting EIC decision. It's been a few weeks now and there's still no progress. Just reject it early if that's the case. It's too slow
(0) 讚! | Georgia Needham

作者: 一条小意远


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-28 21:11:43 評論於
It should be free. I checked the official website
(0) 讚! | 一条小意远

作者: 太玄娟娟


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-12 14:16:53 評論於
Does this magazine charge for publishing articles?
(0) 讚! | 太玄娟娟

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 17:17:38 評論於
Make a list of the most important keywords; Come up with a title that includes all the vocabulary; Remove unnecessary/repeated words and link the remaining ones; Rewrite the title after deleting non-essential information
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 16:52:44 評論於
The Benefits of Regular Exercise
(0) 讚! | 维尔娜菲茨杰拉德

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 11:37:23 評論於
Is there any skill to writing article titles?
(0) 讚! | 上清雨真

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 21:44:09 評論於
How to Write a Better Article Title?
(0) 讚! | 上清雨真

作者: Oliver Jerry


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-10-25 22:57:43 評論於
The wait is too long
(0) 讚! | Oliver Jerry

作者: 上清嘉云


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-09-22 15:39:53 評論於
The review process is taking a long time. It has been over three months under review without any changes. I have sent three reminders during this period, and the response is still that it's under review. I was told that they will provide feedback as soon as there is any news. The last response I received made me feel like even the handling editor is getting impatient
(0) 讚! | 上清嘉云

作者: 上清嘉云


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-09-22 08:43:25 評論於
It has been almost three and a half months since the submission, and it has always been under review. I have sent three or four reminder emails, and each time I was told that it is still under review and feedback will be provided soon! The last email made me feel that the responsible editor is a little impatient! I will continue to wait!
(0) 讚! | 上清嘉云

作者: 墟散莹莹


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-06-03 15:25:37 評論於
How long does the final review take? It's been over two months for me. It's been under review all this time. It's really agonizing
(0) 讚! | 墟散莹莹

作者: 璃月照涵


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-09-18 13:01:45 評論於
The magazine is unreasonable. After being under review for over 5 months, it changed to "awaiting EIC decision." Yesterday, I received a rejection letter saying that the content does not match and will not be sent for review, immediate reject. Almost 6 months to get an "immediate" rejection... I'm speechless. My advice to those in a hurry is not to submit to them, as it wastes too much time
(0) 讚! | 璃月照涵

作者: 璃月照涵


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-08-22 08:19:57 評論於
Review speed: 6.0 Experience sharing: I have been reviewing for nearly 5 months. It's so slow. How can I break this situation? I am feeling a bit impatient and I don't know what's going on
(0) 讚! | 璃月照涵

作者: 新荣mio


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-08-07 13:58:05 評論於
It seems that Chinese people write a lot of articles
(0) 讚! | 新荣mio

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-18 13:26:41 評論於
Everything can only hope for next year, after all, there is no need to worry about the overall rise. Even if it only increases a little each year, it will accumulate over time, which is still good
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-07-13 14:29:18 評論於
9 months before and after, receive!
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-05-16 22:33:10 評論於
Under review for 2 months with no updates, should I still submit elsewhere or wait longer?
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-05-01 09:24:38 評論於
Minor revisions after the first review in 2 months
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-04-23 14:21:08 評論於
Under review for two months
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-02-24 22:25:10 評論於
The review process is taking too long, it's been 5 months since the initial review and still no news, feeling hopeless!
(0) 讚! | 凌霄高洁

作者: 匿名


領域:
審稿時間: 1.0 month(s)
結果: 待定&不明


撰寫評論

2013-03-22 15:01:00 評論於
The impact factor is less than 1 IF 0.87 or so The manuscript entitled " " by ?Et al. was built upon data mining and analysis of gene expression in RA patients and normal controls. Based on the expression data and bioinformatics approach, the authors have identified

(0) 讚! | 匿名

作者: 江南慧红


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2012-10-22 13:13:12 評論於
A newly published journal with fewer articles, but has great potential for development
(0) 讚! | 江南慧红

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [International Journal of Rheumatic Diseases] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*